Ex vivo intracoronary gene transfer of adeno-associated virus 2 leads to superior transduction over serotypes 8 and 9 in rat heart transplants

• Published in: Transplant international Vol. 26; no. 11; p. 1126
• Main Authors: Raissadati, Alireza, Jokinen, Janne J, Syrjälä, Simo O, Keränen, Mikko A I, Krebs, Rainer, Tuuminen, Raimo, Arnaudova, Ralica, Rouvinen, Eeva, Anisimov, Andrey, Soronen, Jarkko, Pajusola, Katri, Alitalo, Kari, Nykänen, Antti I, Lemström, Karl
• Format: Journal Article
• Language: English
• Published: England 01-11-2013
• Subjects: Animals; Dependovirus - classification; Dependovirus - genetics; Genetic Therapy - methods; Genetic Vectors; Heart - virology; Heart Transplantation; Isografts; Luciferases - genetics; Male; Myocardium - metabolism; Rats; Transgenes - genetics; intracoronary delivery; adeno-associated virus; rat; heart transplantation; cardiac transduction
• ISSN: 1432-2277
• DOI: 10.1111/tri.12182

Heart transplant gene therapy requires vectors with long-lasting gene expression, high cardiotropism, and minimal pathological effects. Here, we examined transduction properties of ex vivo intracoronary delivery of adeno-associated virus (AAV) serotype 2, 8, and 9 in rat syngenic and allogenic heart transplants. Adult Dark Agouti (DA) rat hearts were intracoronarily perfused ex vivo with AAV2, AAV8, or AAV9 encoding firefly luciferase and transplanted heterotopically into the abdomen of syngenic DA or allogenic Wistar-Furth (WF) recipients. Serial in vivo bioluminescent imaging of syngraft and allograft recipients was performed for 6 months and 4 weeks, respectively. Grafts were removed for PCR-, RT-PCR, and luminometer analysis. In vivo bioluminescent imaging of recipients showed that AAV9 induced a prominent and stable luciferase activity in the abdomen, when compared with AAV2 and AAV8. However, ex vivo analyses revealed that intracoronary perfusion with AAV2 resulted in the highest heart transplant transduction levels in syngrafts and allografts. Ex vivo intracoronary delivery of AAV2 resulted in efficient transgene expression in heart transplants, whereas intracoronary AAV9 escapes into adjacent tissues. In terms of cardiac transduction, these results suggest AAV2 as a potential vector for gene therapy in preclinical heart transplants studies, and highlight the importance of delivery route in gene transfer studies.